Details for 2017707959

Up to date per 02.04.2026

Actions

Title / Product Name

VERFAHREN ZUR VERWENDUNG VON FXR-AGONISTEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2017707959

EP Publication Number

3419623

E-Number

1433602

Language

PCT Number

IB17050912

Publication Date

02.01.2019 A

29.09.2021 B1

Registration Date

29.09.2021

AT Publication Date

15.10.2021

Application Date

17.02.2017

Registration Number

Priorities

22.02.2016

201662298117 P

11.11.2016

201662420702 P

IPC

A61K 31/46 20060101AFI20170901BHEP

Maximum Duration of Protection

17.02.2037

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

No representatives present

Inventor

LAFFITTE, Bryanc/o Novartis Institute for Functional Genomics Inc. dba The Genomics Institute of the Novartis Research Foundation (GNF) 10675 John Jay Hopkins Drive San Diego, California 92121US

BADMAN, Michaelc/o Novartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

CHEN, Jinc/o Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936US

LINDGREN, Samc/o Novartis Pharma AG Postfach 4002 BaselCH